Book a Demo
Jennifer Larson
Gray shield icon
Is this you?
Claim your profile.

Jennifer Larson

Freelance writer, editor, and content producer

AS SEEN ON
Oncology Nurse Advisor, SingleCare, Hematology Advisor, Everyday Health, Clinical Pain Advisor

Preston's Summary

Jennifer Larson is a freelance writer, editor, and content producer at various online publications. She specializes in covering health care issues, with a focus on consumer health, mental health, oncology, and public health, among other themes in medicine and wellness. Jennifer's work has been featured in numerous outlets, including SELF Magazine, Healthline, and PARADE Publications, Inc.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Informative: 51 %
Data Driven: 38 %
Events: 3 %
Interviews Q&as: 1 %
Opinion: 1 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Oncology
  • Palliative Care
  • Patient Care
  • Consumer Health
  • Drugs & Medication
  • Mental Health Care
  • Healthcare Administration
  • Health News

Pitching Insights

Jennifer Larson's articles predominantly focus on health and medical topics, with a strong emphasis on citing data. She may be particularly interested in pitches that provide access to new or compelling research findings, clinical trial results, or insights from healthcare professionals experienced in the specific conditions or treatments she covers.

Given her high percentage of data citation, Jennifer would likely appreciate outreach from experts who can provide statistical analysis or interpretation of recent studies within the healthcare and pharmaceutical domains. Moreover, sources who can offer evidence-based perspectives on emerging medical treatments or advancements in cancer care are likely to resonate with her coverage interests.

While no specific geographic focus is indicated for Jennifer's work, it’s evident that she concentrates on delivering informative content related to various health conditions and treatment options without being limited by location.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Isabella Hornick

Isabella Hornick

Editorial Assistant
******ck@********om
Publications
Healio
Most recent topics
Not enough data
Mark Leiser

Mark Leiser

Content Strategist
******r@********om
Publications
Healio
Most recent topics
Not enough data
Shenaz Bagha

Shenaz Bagha

Medical Editor
*****a@********om
Publications
Healio
Most recent topics
Not enough data
Tara Haelle

Tara Haelle

Publications
Medscape, Scientific American, yahoo.com, Oncology News Central, Association of Health Care Journalists
Most recent topics
Not enough data
Chelsie Derman

Chelsie Derman

Associate Editor
Publications
HCP Live
Most recent topics
Not enough data
Heather Biele

Heather Biele

Medical Copy Editor
Publications
Healio
Most recent topics
Not enough data

Articles

Hematology Advisor

Gut Microbiota Interventions Impact Immune Checkpoint Inhibitor Efficacy

By: Jennifer Larson

Although immune checkpoint inhibitors (ICIs) have become a mainstay of therapeutic approaches for advanced malignancies, their disruptive effect on the gut microbiota necessitates other actions, such as the use of antibiotics, probiotics, and fecal microbiota transplantation (FMT), to ensure their efficacy and improve survival outcomes for patients. These findings were reported in

Hematology Advisor

Target Trial Emulation Studies: Improving Oncology Research Gaps

By: Jennifer Larson

Although target trial emulation (TTE) has gained a foothold as a source of high quality comparative effectiveness that fills gaps in oncology research, future TTE studies should prioritize prospective protocol registration and follow a well-designed reporting guideline for best results, according to a study recently published in The Oncologist.

© 2026 Intelligent Relations